Cargando…
The Use of the Chuang's Prognostic Scale to Predict the Survival of Metastatic Colorectal Cancer Patients Receiving Palliative Systemic Anticancer Therapy
BACKGROUND: With the increasing number of agents active against cancer, advanced cancer patients including metastatic colorectal cancer (mCRC) patients may continue receiving palliative systemic anticancer therapy (PSAT) near the end-of-life. Validated palliative prognostic models, such as the Chuan...
Autores principales: | Alsirafy, Samy A, Zaki, Omar, Sakr, Amr Y, Farag, Dina E, El-Sherief, Wessam A, Mohammed, Abha A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973493/ https://www.ncbi.nlm.nih.gov/pubmed/27559261 http://dx.doi.org/10.4103/0973-1075.185043 |
Ejemplares similares
-
Prediction of Survival Outcome Using Chuang's Prognostic Scale in Metastatic Breast Cancer
por: Mohammed, Amrallah A, et al.
Publicado: (2021) -
Not Telling Patients Their Cancer Diagnosis in Egypt: Is It Associated With Less Anxiety and Depression and Better Quality of Life?
por: Alsirafy, Samy A., et al.
Publicado: (2022) -
Chuang-Tzu
por: Zhuangzi
Publicado: (1993) -
A shortage of oral morphine in Egypt
por: Alsirafy, Samy A, et al.
Publicado: (2016) -
Editorial to Chuang et al
por: Mantovani, Lorenzo G.
Publicado: (2022)